Marriage Counselors in Grand Rapids, MN Accepting Medicare

8 Marriage Counselors found. Showing 1 - 8

Lois J Meyer, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 419 Timberline Cir Sw, Grand Rapids, MN 55744 Phone: 218-327-7267

Lauren Elizabeth Flood, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 215 Se 2nd Ave, Grand Rapids, MN 55744 Phone: 218-326-1274

Ana L. Pereira, LAMFT Marriage & Family Therapist Medicare: Medicare Enrolled Practice Location: 215 Se 2nd Ave, Grand Rapids, MN 55744 Phone: 218-313-1312

Dr. Philip Michael Valdez, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 413 Se 13th St, Grand Rapids, MN 55744 Phone: 218-999-9908    Fax: 218-999-9959

Jennifer Alstad, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 3130 Se 2nd Ave, Grand Rapids, MN 55744 Phone: 218-326-5114

Scott Peterson, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1880 River Rd, Grand Rapids, MN 55744 Phone: 218-327-3000    Fax: 218-327-1871

Renee' Marie Jore, LMFT, LADC Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 717 Ne 4th St, Grand Rapids, MN 55744 Phone: 218-327-2001    Fax: 218-327-1456

Dana Butler, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 413 Se 13th St, Grand Rapids, MN 55744 Phone: 218-999-9908    Fax: 218-999-9959

News Archive

Amarin completes public offering at $7.60 per ADS

Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that it has completed its previously announced underwritten public offering of American Depositary Shares at a price to the public of $7.60 per ADS.

Phase 1 data of ARIAD Pharmaceuticals' pan-BCR-ABL inhibitor to be presented at the ASH meeting

ARIAD Pharmaceuticals, Inc. today announced that the Company and collaborating investigators from five major oncology research centers in the United States will present data from a Phase 1 clinical trial of ARIAD's investigational, multi-targeted kinase inhibitor and pan-BCR-ABL inhibitor, AP24534, at the 51st Annual Meeting of the American Society of Hematology (ASH) being held in New Orleans, Louisiana, December 5-8, 2009.

Medicare buy-in option: Alternative approach to achieve wider access to care

Medicare-for-all, a solution that would bring United States healthcare policies more in line with other industrial nations, faces strong opposition and is unlikely to be enacted in the foreseeable future.

Complex numeric data on hospital-acquired infections confuses consumers

Patients have difficulty deciphering complex numeric data on healthcare-associated infections used by the Centers for Medicare and Medicaid Services to help consumers choose hospitals, according to a new study published online today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America (SHEA).

Read more Medical News

› Verified 6 days ago